Online but unlawful sales of unapproved and misbranded prescription drugs: Internet pharmacy compliance with <scp>Food and Drug Administration</scp> warning letters
نویسندگان
چکیده
Consumers increasingly use online pharmacies. However, illicit pharmacies endanger consumer welfare with unapproved and counterfeit drugs. By linking Food Drug Administration (FDA) warning letter content observations of the 1108 websites cited in those letters, we identify factors associated FDA-requested compliance active/inactive website status. One five failed to comply FDA recommendations. Findings support cost/benefit, social norm, instrumental theories compliance. Compliance declines cost (e.g., when requests changes more drug categories). Organized crime's norms encourage law breaking; thus, less than other Instrumental theory suggests perceived severity certainty penalties influences In support, political will attention focused on opioid crisis, primarily opioid-related violations these letters increased closures. Finally, recommend improved protection efforts address internet pharmaceutical distribution challenges.
منابع مشابه
The Conundrum of Online Prescription Drug Promotion; Comment on “Trouble Spots in Online Direct-to-Consumer Prescription Drug Promotion: A Content Analysis of FDA Warning Letters”
This commentary discusses pertinent issues from Hyosun Kim’s paper on online prescription drug promotion. The study is well-designed and the findings highlight some of the consequences of the Food and Drug Administration’s (FDA’s) decision to deregulate online advertising of prescription drugs. While Kim’s findings confirm some of the early concerns, they also provide a perspective of implement...
متن کاملTrouble Spots in Online Direct-to-Consumer Prescription Drug Promotion: A Content Analysis of FDA Warning Letters
Background For the purpose of understanding the Food and Drug Administration’s (FDA’s) concerns regarding online promotion of prescription drugs advertised directly to consumers, this study examines notices of violations (NOVs) and warning letters issued by the FDA to pharmaceutical manufacturers. Methods The FDA’s warning letters and NOVs, which were issued to pharmaceutical companies over a...
متن کاملthe conundrum of online prescription drug promotion; comment on “trouble spots in online direct-to-consumer prescription drug promotion: a content analysis of fda warning letters”
this commentary discusses pertinent issues from hyosun kim’s paper on online prescription drug promotion. the study is well-designed and the findings highlight some of the consequences of the food and drug administration’s (fda’s) decision to deregulate online advertising of prescription drugs. while kim’s findings confirm some of the early concerns, they also provide a perspective of implement...
متن کاملThe Tip of the Iceberg of Misleading Online Advertising; Comment on “Trouble Spots in Online Direct-to-Consumer Prescription Drug Promotion: A Content Analysis of FDA Warning Letters”
Kim’s overview of Food and Drug Administration (FDA) regulatory actions from 2005 to 2014 is a comprehensive analysis of the US regulatory experience with online direct-to-consumer advertising (DTCA) of prescription medicines. This experience is of relevance internationally as online DTCA reaches the English-speaking public globally, despite the illegality of DTCA in most countries. The most co...
متن کاملFuture Challenges and Opportunities in Online Prescription Drug Promotion Research; Comment on “Trouble Spots in Online Direct-to-Consumer Prescription Drug Promotion: A Content Analysis of FDA Warning Letters”
Despite increased availability of online promotional tools for prescription drug marketers, evidence on online prescription drug promotion is far from settled or conclusive. We highlight ways in which online prescription drug promotion is similar to conventional broadcast and print advertising and ways in which it differs. We also highlight five key areas for future research: branded drug websi...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Journal of Consumer Affairs
سال: 2023
ISSN: ['1745-6606', '0022-0078']
DOI: https://doi.org/10.1111/joca.12515